Kyowa Hakko Kirin Co Ltd (4151:JP)
1,497.00 +64.00 (+4.47%)
52 WEEK SUMMARY
Mkt Cap 862.996 B
Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.